Family Medicine · Fort Worth, TX
NPI
1639272636
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
5445 Basswood Blvd, Suite 650
Fort Worth, TX, 76137
Phone (817) 485-0161
Medicare paid, 2024
$77K
5,011 services
Medicare patients, 2024
302
Average age 73
Drug cost, 2024
$406K
5,007 prescriptions
Company payments, 2025
$150
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David C Haefeli was code J1010 (injection, methylprednisolone acetate, 1 mg), 3,241 times for 32 patients. In total David C Haefeli billed 5,011 services in 43 codes, and Medicare paid $77K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 3,241 | 32 | $0.09 | $305 |
| 99214 Office E&M - Established | Office | 647 | 267 | $77.23 | $50K |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 266 | 68 | $0.34 | $89.75 |
| 96372 Injection Administration | Office | 226 | 93 | $9.66 | $2,184 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 106 | 106 | $117.21 | $12K |
| 99213 Office E&M - Established | Office | 82 | 80 | $47.46 | $3,891 |
| 81002 Clinical Chemistry | Office | 51 | 42 | $3.41 | $174 |
| 87804 Immunoassay | Office | 34 | 17 | $16.22 | $551 |
| 87426 Immunoassay | Office | 18 | 17 | $31.58 | $568 |
| 87880 Immunoassay | Office | 12 | 12 | $16.20 | $194 |
| 99204 Office E&M - New | Office | 12 | 12 | $55.41 | $665 |
| G0402 Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 11 | 11 | $138.75 | $1,526 |
| 93000 Electrocardiogram | Office | 11 | 11 | $7.64 | $84.08 |
| J1040 Injection, methylprednisolone acetate, 80 mg | Office | 11 | 11 | $4.19 | $46.08 |
By year: 2022 $70K for 1,563 services; 2023 $79K for 1,593 services; 2024 $77K for 5,011 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81002 Clinical Chemistry | 51 | 42 | $3.41 | $174 |
| 87804 Immunoassay | 34 | 17 | $16.22 | $551 |
| 87426 Immunoassay | 18 | 17 | $31.58 | $568 |
| 87880 Immunoassay | 12 | 12 | $16.20 | $194 |
Medicare prescription drug claims, 2024
In 2024, the drug David C Haefeli prescribed most often to Medicare patients was Atorvastatin Calcium, with 193 prescriptions and refills. In total David C Haefeli wrote 5,007 Medicare prescriptions that cost $406K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 193 | 566 | 56 | $1,940 |
| Levothyroxine Sodium Generic | 182 | 547 | 51 | $1,751 |
| Simvastatin Generic | 174 | 486 | 48 | $1,224 |
| Rosuvastatin Calcium Generic | 172 | 492 | 56 | $1,733 |
| Metoprolol Succinate Generic | 150 | 400 | 46 | $2,152 |
| Duloxetine Hcl Generic | 149 | 361 | 35 | $3,069 |
| Omeprazole Generic | 148 | 422 | 47 | $1,693 |
| Metformin Hcl Er Metformin Hcl | 133 | 381 | 38 | $1,576 |
| Montelukast Sodium Generic | 132 | 311 | 42 | $1,222 |
| Amlodipine Besylate Generic | 100 | 290 | 32 | $655 |
| Sertraline Hcl Generic | 100 | 204 | 25 | $652 |
| Tamsulosin Hcl Generic | 95 | 261 | 28 | $1,171 |
| Losartan Potassium Generic | 93 | 273 | 31 | $1,222 |
| Trazodone Hcl Generic | 89 | 189 | 24 | $654 |
| Lisinopril Generic | 77 | 226 | 26 | $354 |
Brand drugs: 546 claims; generic drugs: 4,431 claims; opioid claims: 29.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David C Haefeli $150 ($150 in general payments such as food, travel and fees) from 7 companies. The largest payer was Pfizer Inc. with $37.99.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.